High-sensitivity Troponin-T: Difference between revisions
From Guide to YKHC Medical Practices
mNo edit summary |
mNo edit summary |
||
Line 8: | Line 8: | ||
'''American College of Cardiology''' | '''American College of Cardiology''' | ||
:[https://www.acc.org/latest-in-cardiology/articles/2018/07/16/09/17/high-sensitivity-cardiac-troponin-in-the-evaluation-of-possible-ami ''High-Sensitivity Cardiac Troponin in the Evaluation of Possible AMI (July 16, 2018)''] | :[https://www.acc.org/latest-in-cardiology/articles/2018/07/16/09/17/high-sensitivity-cardiac-troponin-in-the-evaluation-of-possible-ami ''High-Sensitivity Cardiac Troponin in the Evaluation of Possible AMI (July 16, 2018)''] | ||
<br> | |||
[https://www.acep.org/globalassets/sites/acep/media/equal-documents/webinar_chestpainw3_hsctn2.pdf '''ACEP''' Webinar] | |||
<br> | <br> |
Revision as of 07:57, 2 December 2019
The U.S. FDA approved the first high-sensitivity troponin assay, the Roche Diagnostics Elecsys Troponin T (TnT) Gen 5 Stat test, in March 2017.
Yukon-Kuskokwim Delta Regional Hospital (YKDHR) adopted this high-sensitivity cardiac troponin-T (Hs-cTnT) assay on November 12, 2019.
The high-sensitivity and contemporary troponin-T assays can be distinguished by the units in which they are reported: Hs-cTnT is reported in ng/L whereas the contemporary assay (cTnT) is reported in ng/mL.
Helpful Links
American College of Cardiology